Koh David W, Coyle Donna L, Mehta Nimish, Ramsinghani Sushma, Kim Hyuntae, Slama James T, Jacobson Myron K
Division of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington, Kentucky 40536, USA.
J Med Chem. 2003 Sep 25;46(20):4322-32. doi: 10.1021/jm020541u.
Polyadenosine diphosphoribose glycohydrolase (PARG) catalyzes the intracellular hydrolysis of adenosine diphosphoribose polymers. Because structure-activity data are lacking for PARG, the specific inhibitor adenosine diphosphate (hydroxymethyl)pyrrolidinediol (ADP-HPD) was utilized to determine the effects of structure on inhibitor potency using PARG isolated from bovine thymus (bPARG) and recombinant bovine PARG catalytic fragment (rPARG-CF). Both enzymes were strongly inhibited by submicromolar levels of ADP-HPD, but ADP and the phosphorylated pyrrolidine displayed no activity. Utilizing ADP-HPD analogues containing 2-, N(6), or 8-adenosyl substituents or guanine instead of adenine, the importance of adenine ring recognition as well as a correlation between loss of PARG inhibition and the length and bulkiness of 8-adenosyl substituents was shown. Utilization of ADP-HPD analogues lacking one or both pyrrolidine cis-hydroxyls demonstrated their importance for inhibitor binding. Last, the similarity between naturally occurring bPARG and heterologously expressed rPARG-CF was demonstrated. Therefore, readily available rPARG-CF is suitable for use in future studies to determine the structural aspects of PARG.
聚腺苷二磷酸核糖糖苷水解酶(PARG)催化细胞内二磷酸腺苷核糖聚合物的水解。由于缺乏PARG的结构活性数据,因此使用特异性抑制剂二磷酸(羟甲基)吡咯烷二醇(ADP-HPD),利用从牛胸腺中分离的PARG(bPARG)和重组牛PARG催化片段(rPARG-CF)来确定结构对抑制剂效力的影响。两种酶都被亚微摩尔水平的ADP-HPD强烈抑制,但ADP和磷酸化的吡咯烷没有活性。利用含有2-、N(6)或8-腺苷取代基或鸟嘌呤而非腺嘌呤的ADP-HPD类似物,显示了腺嘌呤环识别的重要性以及PARG抑制作用丧失与8-腺苷取代基的长度和体积之间的相关性。利用缺少一个或两个吡咯烷顺式羟基的ADP-HPD类似物证明了它们对抑制剂结合的重要性。最后,证明了天然存在的bPARG与异源表达的rPARG-CF之间的相似性。因此,易于获得的rPARG-CF适用于未来研究以确定PARG的结构方面。